πŸ‡ΊπŸ‡Έ FDA
Patent

US 8604074

Pro-neurogenic compounds

granted A61KA61K31/00A61K31/403

Quick answer

US patent 8604074 (Pro-neurogenic compounds) held by The Board of Regents of the University of Texas System expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
74
CPC classes
A61K, A61K31/00, A61K31/403, A61K31/404, A61K31/415